Skip Navigation

Subscribe
Submit a Manuscript
Sign In

Sign in below to access your subscription for full content

INDIVIDUAL SIGN IN

Sign In|Set Up Account

You will be directed to acponline.org to register and create your Annals account

INSTITUTIONAL SIGN IN

Open Athens|Shibboleth|Log In

SUBSCRIBE

Subscribe to Annals of Internal Medicine.

You will be directed to acponline.org to complete your purchase.

Brief Communications |15 May 2001

Effects of Long-Term Postoperative Interferon-α Therapy on Intrahepatic Recurrence after Resection of Hepatitis C Virus–Related Hepatocellular Carcinoma: A Randomized, Controlled Trial

Shoji Kubo, MD; Shuhei Nishiguchi, MD; Kazuhiro Hirohashi, MD; Hiromu Tanaka, MD; Taichi Shuto, MD; Osamu Yamazaki, MD; Susumu Shiomi, MD; Akihiro Tamori, MD; Hiroko Oka, MD; Sumito Igawa, MD; Tetsuo Kuroki, MD; Hiroaki Kinoshita, MD

Shoji Kubo, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Shuhei Nishiguchi, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Kazuhiro Hirohashi, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Hiromu Tanaka, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Taichi Shuto, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Osamu Yamazaki, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Susumu Shiomi, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Akihiro Tamori, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Hiroko Oka, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Sumito Igawa, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Tetsuo Kuroki, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Hiroaki Kinoshita, MD

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.

Article, Author, and Disclosure Information

From Osaka City University Medical School, Osaka City General Hospital, and Joto Central Hospital, Osaka, Japan.
†Deceased.
Acknowledgments: The authors thank Daniel K. Podolsky, MD, of Massachusetts General Hospital, Harvard Medical School, for critical reading of the manuscript and Hiroyuki Yasuda for statistical analysis.
Grant Support: In part by grants from the Ministry of Education, Science, Sports, and Culture (09671330) and the Ministry of Health and Welfare, Japan.
Requests for Single Reprints: Shuhei Nishiguchi, MD, Third Department of Internal Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan; e-mail, snishiguch@med.osaka-cu.ac.jp.
Current Author Addresses: Drs. Kubo, Hirohashi, Tanaka, Shuto, and Kinoshita: Second Department of Surgery, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Drs. Nishiguchi, Shiomi, and Tamori: Third Department of Internal Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545 8585, Japan.
Dr. Yamazaki: Department of General and Gastrointestinal Surgery, Osaka City General Hospital, 2-13-22 Miyakojimahondori, Miyakojima-ku, Osaka 534-0021, Japan.
Dr. Oka: Department of Gastroenterology, Osaka City General Hospital, 2-13-22 Miyakojimahondori, Miyakojima-ku, Osaka 534-0021, Japan.
Dr. Igawa: Joto Central Hospital, 5-13-47 Shiginonishi, Joto-ku, Osaka 536-0014, Japan.
Author Contributions: Conception and design: S. Kubo, S. Nishiguchi, T. Kuroki, H. Kinoshita.
Analysis and interpretation of the data: S. Kubo, T. Kuroki, S. Nishiguchi.
Drafting of the article: S. Kubo.
Critical revision of the article for important intellectual content: S. Nishiguchi.
Final approval of the article: S. Kubo, S. Nishiguchi, K. Hirohashi, H. Tanaka, T. Shuto, O. Yamazaki, S. Shiomi, A. Tamori, H. Oka, S. Igawa, H. Kinoshita.
Provision of study materials or patients: S. Kubo, S. Nishiguchi, K. Hirohashi, H. Tanaka, T. Shuto, O. Yamazaki, S. Shiomi, A. Tamori, H. Oka, S. Igawa, T. Kuroki, H. Kinoshita.
Statistical expertise: S. Kubo, S. Nishiguchi.
Obtaining of funding: S. Kubo, H. Kinoshita.
Administrative, technical, or logistic support: S. Kubo, S. Nishiguchi, K. Hirohashi, H. Tanaka, T. Shuto, O. Yamazaki, S. Shiomi, A. Tamori, H. Oka, S. Igawa, T. Kuroki.
Collection and assembly of data: S. Kubo, S. Nishiguchi, K. Hirohashi, H. Tanaka, O. Yamazaki, S. Shiomi, A. Tamori, H. Oka, S. Igawa.

Abstract

Background:

Interferon therapy decreases the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.

Objective:

To evaluate effects of interferon-α on recurrence after resection of hepatitis C virus–related hepatocellular carcinoma.

Design:

Randomized, controlled trial.

Setting:

University hospital, medical center, and affiliated hospital in Osaka, Japan.

Patients:

30 men were randomly allocated after resection to the interferon-α group (n = 15) or the control group (n = 15).

Intervention:

Patients in the interferon-α group received interferon-α, 6 MIU intramuscularly daily for 2 weeks, then three times weekly for 14 weeks, and finally twice weekly for 88 weeks.

Measurements:

Recurrence rates after resection.

Results:

Recurrent tumors were detected in 5 patients in the interferon-α group and in 12 control patients. The recurrence rate was significantly lower in the interferon-α group than in the control group (P = 0.037).

Conclusion:

Postoperative interferon-α therapy appears to decrease recurrence after resection of hepatitis C virus–related hepatocellular carcinoma.

FULL TEXT

Not Available

Citations

©

2001 American College of Physicians

Related Point of Care

Hepatitis C Virus

Annals of Internal Medicine; 165 (5): ITC33-ITC48

Hepatitis C Virus (Japanese Version)

Annals of Internal Medicine; 165 (5): JITC33-JITC48

Multiple Sclerosis

Annals of Internal Medicine; 160 (7): ITC4-1

View MoreView Less